BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27185595)

  • 1. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
    Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK
    Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin.
    Siddiqui A; Bhaumik D; Chinta SJ; Rane A; Rajagopalan S; Lieu CA; Lithgow GJ; Andersen JK
    J Neurosci; 2015 Sep; 35(37):12833-44. PubMed ID: 26377470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
    Khang R; Park C; Shin JH
    Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
    Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
    Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
    Ferretta A; Gaballo A; Tanzarella P; Piccoli C; Capitanio N; Nico B; Annese T; Di Paola M; Dell'aquila C; De Mari M; Ferranini E; Bonifati V; Pacelli C; Cocco T
    Biochim Biophys Acta; 2014 Jul; 1842(7):902-15. PubMed ID: 24582596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
    Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
    Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
    Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
    J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
    Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
    Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
    Kang H; Shin JH
    Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons.
    Kumar M; Acevedo-Cintrón J; Jhaldiyal A; Wang H; Andrabi SA; Eacker S; Karuppagounder SS; Brahmachari S; Chen R; Kim H; Ko HS; Dawson VL; Dawson TM
    Stem Cell Reports; 2020 Sep; 15(3):629-645. PubMed ID: 32795422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.
    Hasegawa K; Yasuda T; Shiraishi C; Fujiwara K; Przedborski S; Mochizuki H; Yoshikawa K
    Nat Commun; 2016 Mar; 7():10943. PubMed ID: 26971449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease.
    Pacelli C; De Rasmo D; Signorile A; Grattagliano I; di Tullio G; D'Orazio A; Nico B; Comi GP; Ronchi D; Ferranini E; Pirolo D; Seibel P; Schubert S; Gaballo A; Villani G; Cocco T
    Biochim Biophys Acta; 2011 Aug; 1812(8):1041-53. PubMed ID: 21215313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.
    Stevens DA; Lee Y; Kang HC; Lee BD; Lee YI; Bower A; Jiang H; Kang SU; Andrabi SA; Dawson VL; Shin JH; Dawson TM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11696-701. PubMed ID: 26324925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
    Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
    Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of HIPK2 Protects Neurons from Mitochondrial Toxins by Regulating Parkin Protein Turnover.
    Zhang J; Shang Y; Kamiya S; Kotowski SJ; Nakamura K; Huang EJ
    J Neurosci; 2020 Jan; 40(3):557-568. PubMed ID: 31776210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.